Prevalence of new‐onset diabetes following COVID ‐19 infection: A systematic review and meta‐analysis
Authors' conclusion
This systematic review and meta-analysis revealed a notable increase in T2DM or combined (T1DM, T2DM, or undefined) conditions. As such, it may be important to understand the underlying factors contributing to increased prevalence.
Study context
- Population
- Adults (≥ 18 years) following SARS-CoV-2 infection; English-language studies33 articles
- Outcome
- Prevalence of new-onset diabetes following SARS-CoV-2 infection
Methodological detailsrandom-effects meta-analysis, random-effects meta-regression, dual independent review, quality assessed with New Castle Ottawa Scale
- Random-effects meta-analysis
- Random-effects meta-regression
- Dual independent review
- Quality assessed with New Castle Ottawa Scale
Pooled result
As reported in the abstract
Prevalence of new-onset diabetes (combined T1DM and T2DM or undefined)
Pooled prevalence, new-onset diabetes (combined T1DM and T2DM or undefined)
8.33%
95% CI 7.47, 9.18%; p < 0.001; I2, 99.68%
Pooled prevalence, new-onset T2DM
8.92%
95% CI 7.88%, 9.96%; p < 0.001; I2 = 99.96%
Pooled prevalence, new-onset T1DM
0.86%
95% CI 0.0072%, 0.0099%; p < 0.001; I2 = 99.94%
Further pooled results
Meta-regression: age, sex, follow-up duration
- No significant relationship identified with age, sex, or follow-up duration at the study level
Original publication
Prevalence of new‐onset diabetes following COVID ‐19 infection: A systematic review and meta‐analysis. Diabetes Obes Metab. Published 28 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →